ArticlePloS one2026
The burden and epidemiology of orofacial clefts in Iran from 1990 to 2023: a Global Burden of Disease study with subnational socio-demographic index analysis.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundOrofacial clefts (OFCs) are among the most frequent congenital craniofacial malformations worldwide. These conditions impose lifelong functional, psychological, and socioeconomic burdens. In Iran, despite several hospital-based and regional studies, an updated national and subnational assessment of OFC burden has been lacking. This study aimed to estimate the incidence, prevalence, disability-adjusted life years (DALYs), and mortality attributable to OFCs in Iran and its 31 provinces from 1990 to 2023, and to explore their associations with the sociodemographic index (SDI).
methodsData were obtained from the Global Burden of Disease (GBD) Study 2023. OFCs were defined according to ICD-10 codes Q35-Q37. GBD modeled estimates were generated using the DisMod-MR 2.1 meta-regression framework. The DisMod-MR 2.1 meta-regression model was applied to derive estimates of metrics. Rates were age-standardized per 100,000 population, and 95% uncertainty intervals (UIs) were calculated. The relationship between OFC burden and SDI was assessed descriptively using smoothing splines models.
resultsIn 2023, Iran recorded 1,208.9 (917.1-1,581.4) new OFC cases, corresponding to an age-standardized incidence rate of 2.5 per 100,000. Prevalence reached 77.3 (62.3-94.7) per 100,000, and DALYs were 6.9 (4.1-10.5) per 100,000. Since 1990, DALY and mortality rates decreased by 88.8% and 96.1%, respectively, while prevalence remained largely stable. The highest prevalence was seen in Tehran (108.3 per 100,000) and the lowest in Isfahan (49.1 per 100,000). The greatest DALY burden occurred among children under five years. There was a negative relationship between SDI and DALY rates.
conclusionsThe national burden of OFCs in Iran has substantially declined over the past three decades. These findings highlight the need for sustained efforts to improve cleft prevention, early detection, and access to specialized care to further reduce the burden and promote health equity across Iran.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.